-+ 0.00%
-+ 0.00%
-+ 0.00%

OCUGEN RECEIVES PROVISIONAL APPROVAL AND PRIORITY DESIGNATION UNDER THE LONGEVITY AND REGENERATIVE THERAPIES ACT IN THE BAHAMAS TO PROVIDE OCU400 TO PATIENTS FOR TREATMENT OF RETINITIS PIGMENTOSA

Reuters·09/25/2026 11:02:00

Please log in to view news